Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel method for preparing dihydroxy acid HMG CoA reductase inhibitor

A hydroxycarboxylate, alkyl technology, applied in the field of preparing dihydroxyacid HMG-CoA reductase inhibitors, can solve problems such as difficult operation, complex structure, difficult synthesis, etc., and achieves less environmental pollution, high yield, easy effect of operation

Active Publication Date: 2006-08-23
CHANGZHOU YABANG PHARMA
View PDF4 Cites 26 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Due to the complex structure of statins, the synthesis is relatively difficult. There are many synthetic methods in the prior art, but they all have defects such as low yield, long steps, high cost, and difficult operation. The invention provides a method for preparing dihydroxy acid HMG-CoA New approach to reductase inhibitors addresses these issues

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel method for preparing dihydroxy acid HMG CoA reductase inhibitor
  • Novel method for preparing dihydroxy acid HMG CoA reductase inhibitor
  • Novel method for preparing dihydroxy acid HMG CoA reductase inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Example 1: Preparation of compound (B) 4-(4-fluorobenzene)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)-5-pyrimidinecarbaldehyde:

[0058]Add 28.0 g of pyridinium chlorochromate (PCC) and 24.6 g of anhydrous sodium acetate to 300 ml of dry dichloromethane, stir, and add compound (A) [4-(4-fluorobenzene)-6-iso Propyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]methanol 35.3g and 200ml dichloromethane prepared solution, stirred for 1h, filtered, filtrate 1N hydrochloric acid 500ml, 1N NaOH 500ml, Wash with 500 ml of saturated brine, dry over anhydrous magnesium sulfate, remove dichloromethane under reduced pressure, and perform column chromatography on the residue with dichloromethane as the eluent to obtain 29.1 g of the crystalline target product (yield: 82.9%).

Embodiment 2

[0059] Embodiment 2: the preparation of compound (D):

[0060] Add 13.0 g of trimethyl phosphite to 200 ml of toluene, raise the temperature to reflux, add compound (C) 2-[(4R,6S)-6-bromomethyl-2,2-dimethyl-1,3-dioxo -4-yl] tert-butyl acetate 32.3g and toluene 200ml prepared solution, reflux reaction for 3h, remove toluene under reduced pressure, add 500ml of water, extract with 200ml of chloroform×3, dry over anhydrous magnesium sulfate, remove chloroform under reduced pressure, The residue was subjected to column chromatography with ethyl acetate as the eluent to obtain 31.7 g of the target product (yield: 90.1%).

Embodiment 3

[0061] Embodiment 3: the preparation of compound (E)

[0062] Add 15.3g of LiCl and 42.2g of compound (D) to 300ml of dry dichloromethane under the protection of argon, stir, add 12.2g of triethylamine dropwise at 0°C, and then add 35.1g of compound (B) and dichloromethane dropwise 200ml of the prepared solution was stirred at 20°C for 1h, 300ml of saturated ammonium chloride solution was added to the reaction solution, the layers were separated, the aqueous phase was extracted with 200ml of dichloromethane × 2, the organic phases were combined, dried over anhydrous magnesium sulfate, and the dichloromethane was removed under reduced pressure. Chloromethane, column chromatography of the residue, eluent (n-hexane: ethyl acetate = 5: 1), to obtain 40.7 g of the target product (yield: 70.5%).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides the preparation process of the compound as shown.

Description

Technical field: [0001] The present invention relates to a new method for preparing dihydroxy acid HMG-CoA reductase inhibitors. Background technique: [0002] Dihydroxy acid HMG-CoA reductase inhibitors, also known as: 3-hydroxy-3-methylglutaryl-coenzyme reductase inhibitor A (3-hydroxy-3-methylglutaryl-coenzymeA, HMG-CoA), is a class of A new type of blood lipid-lowering drug, currently the drug of choice for clinical prevention and treatment of atherosclerosis. [0003] Since the first statin drug mevastatin (mevastatin) came out in 1976, statin drugs have developed to the third generation. At present, there are five kinds of statin drugs commonly used in the world (in order of appearance): lovastatin (lovastatin), pravastatin (pravastatin), simvastatin (simvastatin), fluvastatin (fluvastatin) and atorvastatin (atorvastatin). Not long ago, cerivastatin (cerivastatin), which has a powerful lipid-lowering effect and is only used in micrograms, has been used in the intern...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D405/06C07D239/42A61P9/10
Inventor 王思清吴宾徐树行
Owner CHANGZHOU YABANG PHARMA
Features
  • Generate Ideas
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More